Mason & Associates Inc Takes Position in The Allstate Co. (NYSE:ALL)

Mason & Associates Inc acquired a new position in shares of The Allstate Co. (NYSE:ALL) in the 3rd quarter, according to its most recent filing with the SEC. The fund acquired 4,598 shares of the insurance provider’s stock, valued at approximately $872,000.

Other large investors have also recently made changes to their positions in the company. Northwest Investment Counselors LLC purchased a new stake in shares of Allstate during the 3rd quarter valued at approximately $28,000. Versant Capital Management Inc lifted its position in Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after buying an additional 78 shares during the last quarter. Family Firm Inc. purchased a new position in Allstate during the second quarter worth about $38,000. MCF Advisors LLC increased its position in shares of Allstate by 33.9% during the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock valued at $53,000 after acquiring an additional 84 shares during the last quarter. Finally, First Command Advisory Services Inc. purchased a new stake in shares of Allstate in the 2nd quarter valued at approximately $58,000. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Allstate

In other Allstate news, EVP Elizabeth Brady sold 49,481 shares of the stock in a transaction dated Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the completion of the transaction, the executive vice president now directly owns 19,163 shares of the company’s stock, valued at approximately $3,431,901.67. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Allstate news, CEO Thomas J. Wilson sold 90,000 shares of the stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the sale, the chief executive officer now owns 88,552 shares in the company, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Elizabeth Brady sold 49,481 shares of the company’s stock in a transaction on Friday, August 16th. The shares were sold at an average price of $179.09, for a total value of $8,861,552.29. Following the completion of the sale, the executive vice president now owns 19,163 shares in the company, valued at $3,431,901.67. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 192,530 shares of company stock valued at $34,967,665. Corporate insiders own 1.80% of the company’s stock.

Analysts Set New Price Targets

ALL has been the topic of a number of research analyst reports. UBS Group boosted their target price on Allstate from $215.00 to $216.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. StockNews.com lowered shares of Allstate from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 21st. Raymond James increased their price objective on Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research note on Friday, October 4th. BMO Capital Markets increased their price target on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Finally, TD Cowen boosted their price objective on Allstate from $193.00 to $224.00 and gave the stock a “buy” rating in a research report on Tuesday, September 3rd. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $206.44.

Allstate Stock Performance

Shares of Allstate stock traded up $0.11 during trading on Thursday, reaching $192.89. The company’s stock had a trading volume of 251,352 shares, compared to its average volume of 1,534,622. The company has a 50-day moving average price of $187.73 and a two-hundred day moving average price of $174.23. The Allstate Co. has a fifty-two week low of $122.53 and a fifty-two week high of $198.79. The firm has a market cap of $50.91 billion, a PE ratio of 42.56, a P/E/G ratio of 1.74 and a beta of 0.48. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49.

Allstate (NYSE:ALL) last announced its earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share for the quarter, topping the consensus estimate of $0.33 by $1.28. The business had revenue of $15.71 billion during the quarter, compared to the consensus estimate of $14.04 billion. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The business’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($4.42) earnings per share. On average, analysts forecast that The Allstate Co. will post 15.19 EPS for the current year.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.